---
schema_version: "secwatch.filing_event.v1"
accession: "0000886163-25-000040"
form_type: "8-K"
ticker: "LGND"
cik: "0000886163"
company_name: "LIGAND PHARMACEUTICALS INC"
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:51:44.865906+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Ligand shareholders re-elect all eight directors, ratify auditor, and approve say-on-pay

## Summary
- All eight director nominees elected, with each receiving >15.5M votes for (excluding broker non-votes).
- Ratification of Ernst & Young as independent auditor for FY2025 passed with 17.27M votes for.
- Non-binding advisory vote on named executive officer compensation approved with 15.58M votes for.
- Broker non-votes totaled 1.36M on director elections and say-on-pay; none on auditor ratification.

## SEC filing metadata
- accession: 0000886163-25-000040
- form_type: 8-K
- ticker: LGND
- cik: 0000886163
- company_name: LIGAND PHARMACEUTICALS INC
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/886163/000088616325000040/0000886163-25-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/886163/000088616325000040/lgnd-20250609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000886163-25-000040
- JSON: https://secwatch.observer/filing/0000886163-25-000040.json
- Plain text: https://secwatch.observer/filing/0000886163-25-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.